The Deleterious Influence of Tenofovir-Based Therapies on the Progression of Atherosclerosis in HIV-Infected Patients

<table>Changes in the expression levels of <i>CCL2</i>, <i>CCR2,</i> and <i>CCR5</i> genes. The expression levels of selected cytokine-related genes in blood cells of HIV-infected patients in relation to HIV viral load (a), total cholesterol levels (b), and HDL-cholesterol (HDL-c) concentration (c).</table>

Mediators of Inflammation

fig3

Figure 3

Figure 3: The Deleterious Influence of Tenofovir-Based Therapies on the Progression of Atherosclerosis in HIV-Infected Patients 